1. 1193-65-3
2. Quinuclidin-3-one Hydrochloride
3. 3-quinuclidone Hydrochloride
4. 1-azabicyclo[2.2.2]octan-3-one Hydrochloride
5. 3-quinuclidinone Hcl
6. 3-quinuclidinone, Hcl
7. 1-azabicyclo[2.2.2]octan-3-one, Hydrochloride
8. Mfcd00137391
9. 1-azabicyclo[2.2.2]octan-3-one;hydrochloride
10. 3-quinuclidnone Hydrochloride
11. 1-azabicyclo(2.2.2)octan-3-one, Hydrochloride
12. 1-azabicyclo[2.2.2]octan-3-one;hydron;chloride
13. 1-azabicyclo(2.2.2)octan-3-one, Hydrochloride (1:1)
14. C7h12clno
15. 1-azabicyclo[2.2.2]octan-3-one, Hydrochloride (1:1)
16. Einecs 214-776-5
17. Nsc 91498
18. C7h11nohcl
19. 3-quinuclidnone Hcl
20. Schembl232525
21. Quinuclidin-3-one Chlorhydrate
22. Chembl554124
23. Schembl3641783
24. 8.3-quinuclidinone Hcl
25. Dtxsid4061599
26. Quinuclidine-3-one Hydrochloride
27. Quinuclidine-3-one-hydrochloride
28. 3-quinuclidone Hydrochloride, 97%
29. Bcp26517
30. Cs-b0277
31. Nsc91498
32. Nsc-91498
33. Akos015848573
34. Akos015897101
35. Ac-2041
36. Am86381
37. Sb31630
38. (1s,4s)-quinuclidin-3-one Hydrochloride
39. As-13094
40. As-44249
41. Bp-12544
42. Sy003508
43. Db-028580
44. Ft-0616382
45. Q0052
46. En300-21346
47. 1-azabicyclo[2.2.2]-octan-3-one Hydrochloride
48. 193q653
49. Q-100090
50. F0001-0318
51. Quinuclidin-3-one Hydrochloride;3-quinuclidone Hydrochloride
52. 3-quinuclidinone Hydrochloride (6ci,7ci,8ci) 3-oxoquinuclidinehydrochloride
1. 1193-65-3
| Molecular Weight | 161.63 g/mol |
|---|---|
| Molecular Formula | C7H12ClNO |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 0 |
| Exact Mass | 161.0607417 g/mol |
| Monoisotopic Mass | 161.0607417 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 136 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
BUILDING BLOCK
END USE APIs
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
First company in Turkey to manufacturer APIs & an ideal partner for multi-layered & Complex Chemical Synthesis.
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.
ASolution Pharmaceuticals: Your Partner for cGMP Development & Manufacturing Services – Supplying APIs, FDFs, and Specialty Molecules...
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Century has been an API manufacturer for over 30 years & is the partner of choice for multipurpose custom manufacturing projects.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
Minakem is manufacturing small molecules APIs including corticosteroids
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RELATED INTERMEDIATES
LOOKING FOR A SUPPLIER?
